Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

General Press Releases Wednesday May 15, 2019 11:38
BOONE, North Carolina--15 May--PRNewswire/InfoQuest

Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodies and fusion protein molecules for the pulmonary delivery of Leads' antibodies and molecules.   Using Pneuma's digital inhaler platform, the agreement provides access to the untapped potential of pulmonary delivery of Leads' immuno-oncology therapies in the treatment of oncologic or immune-mediated lung diseases.

In a recent publication, Pneuma announced the completion of a study demonstrating the feasibility of antibody delivery to the lungs via its digital inhaler platform.   This study, conducted in an animal model, indicates that the Pneuma digital inhaler platform may provide a method for the pulmonary delivery of monoclonal antibody therapies, enabling the targeted treatment of oncologic or immune-mediated lung diseases.

"This collaboration is an exciting development for the field of immuno-oncology," said Ronald Bukowski, MD, physician emeritus, Cleveland Clinic Foundation.   "Approaches utilizing the regional administration of novel checkpoint inhibitors may provide new treatment opportunities for patients with a variety of malignancies."

"We are pleased to enter into a license agreement for Leads Biolabs monoclonal antibody portfolio," said Pneuma Chief Executive Officer and co-founder Eric Hunter. "We look forward to working with their team to conduct studies that may lead to positive change in the future treatment of non-small cell lung cancer."

Dr. Xiaoqiang Kang, Chairman and CEO of Leads Biolabs, said: "We are very excited to have this license agreement with Pneuma Respiratory. The commitment by a leader in digital pulmonary delivery of drugs is an endorsement of the value of our portfolio. We believe that Pneuma's digital inhaler technology combined with our antibody drugs will create very exciting new opportunities for both companies. We look forward to working with Pneuma to move our candidates into the clinic as quickly as possible."

About Pneuma Respiratory:

Launched in 2015, Pneuma Respiratory is a pharmaceutical company based in Boone, North Carolina. With a global team of researchers, physicians, designers and engineers, Pneuma has created the first fully integrated digital breath-activated inhaler. This inhaled delivery system includes digital micro-fluidics integrated with Bluetooth technology capable of providing feedback on drug delivery to patients, family members, and health care providers. Using Pneuma's digital droplet ejector technology, Pneuma's device has the potential to ultimately deliver a spectrum of novel therapies, including biologics, to the lungs. The first breath-activated digital inhaler (BDI) is currently in use for investigational purposes only and is not yet commercially available. For more information, please visit www.pneumarespiratory.com .

About Leads Biolabs, Inc.:

Leads Biolabs, Inc., a Maryland Corporation, is the fully-owned subsidiary of a US-Sino joint venture company, Nanjing Leads Biolabs Co., Ltd. based in Nanjing, China. Leads Biolabs is an innovation-driven biopharmaceutical company with a rich portfolio of more than 10 novel mono-targeted or bispecific antibody drug projects for cancer immunotherapy and other major diseases to fulfill unmet medical needs. For more information, please visit www.leadsbiolabs.com .

PRIMARY MEDIA CONTACT:
Christy Anglin
canglin@pneumarespiratory.com
Logo - https://mma.prnewswire.com/media/887236/Pneuma_Respiratory_Logo.jpg

Latest Press Release

Get the best of ALL worlds with our brand new Sunday Brunch

The World restaurant, the place in Bangkok to discover exquisite flavors and exotic cuisine from all corners or the globe, is launching a brand new brunch to be held on the second Sunday of every month. Spanning a 'live', cooked-by-order station, as well...

AXA Insurance Launched AXA Preferred Garage Program to Better Serve Its Car Insurance Customers

AXA Insurance, a leading general insurance provider in Thailand and a part of the Number ONE Global Insurance Brand for the 10th consecutive year1 launched 'AXA Preferred Garage' program, a collection of high-quality garages to better serve its car...

DGA เข้าร่วมงานสัมมนาวิชาการระดับนานาชาติด้าน Digital Transformation ระดับภูมิภาคเอเชีย โดยสถาบัน KIEA ประเทศเกาหลี

สำนักงานพัฒนารัฐบาลดิจิทัล (องค์การมหาชน) สพร. หรือ DGA ได้ร่วมแบ่งปันความรู้และประสบการณ์ทางในงานสัมมนาวิชาการระดับนานาชาติ "International Conference on 4th Industrial Revolution Technologies for National Information Management and Digital...

Malaysia vastly undercounting poverty, says UN rights expert

Malaysia lays claim to the world's lowest national poverty rate by using an unduly low poverty line that does not reflect the cost of living and by excluding vulnerable populations from its official figures, said UN human rights expert Philip Alston at...

UN Fact-Finding Mission on Myanmar Calls for Justice for Victims of Sexual and Gender-based Violence

The U.N. Independent International Fact-Finding Mission on Myanmar said the country's military must stop using sexual and gender-based violence to terrorise and punish ethnic minorities. The Mission said the brutal tactic was still being employed in...

Related Topics